HHS Secretary Provides Statement On Launch Of Public-Private Partnership For COVID-19 Research Response

HHS: Secretary Azar Statement on New Partnership to Develop National Strategy for COVID-19 Therapies and Vaccines
In a statement on the launch of a public-private partnership among U.S. agencies, the European Medicines Agency, and private pharmaceutical companies, to develop a national strategy for a coordinated research response to the COVID-19 pandemic, HHS Secretary Alex Azar said, “To save lives and bring life back to normal in the United States and around the world, we need COVID-19 vaccines and therapies on the market as soon as possible. By bringing together 16 pharmaceutical companies and five government agencies here and abroad, the [Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)] partnership will accelerate the amazing work being done every day by scientists and innovators inside and outside of government” (4/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.